Evidence map›Paper›PMID 32412400›Full record

ArticleCardiology in the young2020

COVID-19 and Kawasaki syndrome: should we really be surprised?

Rohit S Loomba, Enrique Villarreal, Saul Flores

Abstract read
In one paragraph

Article in Cardiology in the young, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. [COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult].Revista espanola de anestesiologia y reanimacion · 2022
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Covid-19 and Kawasaki syndrome.Cardiology in the young · 2020
    Article
  8. Kawasaki-like Syndrome as an Emerging Complication of SARS-CoV-2 Infection in Young Adults.European journal of case reports in internal medicine · 2020
    Article
  9. The Cutaneous Manifestations Associated with COVID-19: A review.American journal of dermatological research and reviews · 2020
    Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Rohit S LoombaAdvocate Children's Hospital, Chicago Medical School/Rosalind Franklin University of Medicine and Science, Chicago, IL, USA.ORCID https://orcid.org/0000-0002-9116-2835
Enrique VillarrealTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Nuevo, Leon, Mexico.
Saul FloresTexas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hyperinflammatory response to COVID-19 is being described in children. While this presents, and responds to management, similar to that of Kawasaki Disease it is being coined a new entity. But is it really? We explore how this phenomenon may be Kawasaki Disease with a new trigger.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19Diagnosis, DifferentialHumansMucocutaneous Lymph Node SyndromePandemicsPneumonia, ViralSARS-CoV-2coronavirusCOVIDinflammationKawasakimyocarditispandemic

Identifiers

PMID32412400
PMCPMC7322149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.